Medtronic (BSP:MDTC34) Cyclically Adjusted FCF per Share: R$11.39 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:MDTC34 Medtronic PLC BSP:MDTC34
72 GF Score
Price R$212.73
GF Value R$247.49
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Cyclically Adjusted FCF per Share?

Medtronic BSP:MDTC34 72 Cyclically Adjusted FCF per Share is R$11.39 as of Apr. 2026. GuruFocus rates BSP:MDTC34 with a GF Score™ of 72/100 and a GF Value™ of R$247.49 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Medtronic's adjusted free cash flow per share for the three months ended in Apr. 2026 was R$4.075. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is R$11.39 for the trailing ten years ended in Apr. 2026.

During the past 12 months, Medtronic's average Cyclically Adjusted FCF Growth Rate was 4.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 1.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 2.40% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Medtronic was 30.10% per year. The lowest was 1.00% per year. And the median was 9.65% per year.

As of today (2026-07-16), Medtronic's current stock price is R$212.73. Medtronic's Cyclically Adjusted FCF per Share for the quarter that ended in Apr. 2026 was R$11.39. Medtronic's Cyclically Adjusted Price-to-FCF of today is 18.68.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Medtronic was 34.08. The lowest was 15.74. And the median was 23.22.


Medtronic  (BSP:MDTC34) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Medtronic's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=212.73/11.39
=18.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Medtronic was 34.08. The lowest was 15.74. And the median was 23.22.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Medtronic Cyclically Adjusted FCF per Share Related Terms


Medtronic Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Medtronic's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Cyclically Adjusted FCF per Share Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.64 11.07 11.33 12.20 11.39

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.20 12.65 11.91 11.39 11.39

BSP:MDTC34 vs SYK, BSX, EW: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Medtronic's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Medtronic's Cyclically Adjusted Price-to-FCF falls into.


BSP:MDTC34
72GF Score
Medtronic PLC BSP:MDTC34
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medtronic's adjusted Free Cash Flow per Share data for the three months ended in Apr. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=4.075/128.4300*128.4300
=4.075

Current CPI (Apr. 2026) = 128.4300.

Medtronic Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201607 1.421 100.872 1.809
201610 1.377 99.776 1.772
201701 2.029 99.178 2.627
201704 1.639 100.773 2.089
201707 0.534 100.673 0.681
201710 0.772 100.374 0.988
201801 2.075 99.377 2.682
201804 0.931 100.374 1.191
201807 1.975 101.470 2.500
201810 1.322 101.271 1.677
201901 2.421 100.075 3.107
201904 2.526 102.068 3.178
201907 1.690 101.969 2.129
201910 2.393 101.969 3.014
202001 3.247 101.371 4.114
202004 2.194 101.969 2.763
202007 -0.109 101.570 -0.138
202010 3.287 100.474 4.202
202101 3.944 101.171 5.007
202104 2.805 103.065 3.495
202107 1.739 103.763 2.152
202110 3.063 105.557 3.727
202201 3.887 106.255 4.698
202204 2.951 110.242 3.438
202207 1.321 113.262 1.498
202210 1.181 115.315 1.315
202301 2.421 114.470 2.716
202304 3.922 118.213 4.261
202307 0.938 119.903 1.005
202310 0.380 121.111 0.403
202401 3.930 119.179 4.235
202404 4.556 121.232 4.827
202407 0.996 122.560 1.044
202410 1.211 121.956 1.275
202501 4.898 121.473 5.179
202504 4.652 123.888 4.823
202507 1.255 124.613 1.293
202510 0.955 125.410 0.978
202601 4.755 124.690 4.898
202604 4.075 128.430 4.075

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of R$11.39 mean?
Medtronic (BSP:MDTC34) has a Cyclically Adjusted FCF per Share of R$11.39 as of Apr. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Medtronic and its competitors.
Is Medtronic's Cyclically Adjusted FCF per Share too high?
Medtronic's current Cyclically Adjusted FCF per Share is R$11.39. Overall, Medtronic has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Cyclically Adjusted FCF per Share compare to SYK and BSX?
Medtronic's Cyclically Adjusted FCF per Share of R$11.39 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Medtronic and its competitors. Medtronic's current Cyclically Adjusted FCF per Share is R$11.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (BSP:MDTC34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$247.49, compared to a current price of R$212.73 — trading 14% below its estimated fair value. The current Cyclically Adjusted FCF per Share is R$11.39. Medtronic's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Medtronic (BSP:MDTC34), the current Cyclically Adjusted FCF per Share is R$11.39 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (BSP:MDTC34) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of R$212.73 is trading 14% below its estimated GF Value™ of R$247.49. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for BSP:MDTC34:

  • Cyclically Adjusted FCF per Share: R$11.39
  • GF Value™: R$247.49 vs. price of R$212.73 (14% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the BSP:MDTC34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
72GF Score

Get the complete analysis for BSP:MDTC34

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$212.73
Price
R$247.49
GF Value